Cargando…
Plasma Donor-derived Cell-free DNA Levels Are Increased During Acute Cellular Rejection After Lung Transplant: Pilot Data
Telehealth platforms with remote phlebotomy and biomarker implementation represent a novel paradigm for surveillance after lung transplantation (LT). In a pilot study, we investigated donor-derived cell-free DNA (dd-cfDNA) in plasma using a clinical-grade “next-generation sequencing” assay. METHODS....
Autores principales: | Sayah, David, Weigt, S. Samuel, Ramsey, Allison, Ardehali, Abbas, Golden, Jeff, Ross, David J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515612/ https://www.ncbi.nlm.nih.gov/pubmed/33062841 http://dx.doi.org/10.1097/TXD.0000000000001063 |
Ejemplares similares
-
Clinical Validation of a Plasma Donor-derived Cell-free DNA Assay to Detect Allograft Rejection and Injury in Lung Transplant
por: Rosenheck, Justin P., et al.
Publicado: (2022) -
Selective Recruitment of Large Lower Lobe Atelectasis on Donor Back Table in Rejected Donor Lungs
por: Okamoto, Toshihiro, et al.
Publicado: (2019) -
Cyclophosphamide for Refractory Acute Cellular Rejection After Lung Transplantation
por: Naik, Chetan, et al.
Publicado: (2018) -
Pulmonary Allograft Versus Host Disease
por: Dai, David W., et al.
Publicado: (2017) -
Intragraft Hyaluronan Increases in Association With Acute Lung Transplant Rejection
por: Hostetler, Haley P., et al.
Publicado: (2021)